Immunochemical studies of foot-and-mouth disease-Reference-Cited by-同舟云学术

Immunochemical studies of foot-and-mouth disease

Published:1970-12 Issue:4 Volume:30 Page:343-352
ISSN:0304-8608
Container-title:Archiv f�r die gesamte Virusforschung
language:en
Short-container-title:Archiv f Virusforschung

Author:

Wagner G. G.,Card J. L.,Cowan K. M.

Publisher

Springer Science and Business Media LLC

Subject

Virology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01258364.pdf

Reference16 articles.

1. Albertsson, P. A.: ?Partition of Cell Particles and Macromolecules.? Wiley, New York, 1960.

2. Bachrach, H. L., andS. S. Breese, Jr.: In: ?Methods in Virology?,K. Maramorosch andH. Koprowski, eds., vol. 4, p. 351, New York: Academic Press, 1968.

3. Bachrach, H. L., R. Trautman, andS. S. Breese, Jr.: Chemical and physical properties of virtually pure foot-and-mouth disease virus. Amer. J. vet. Res.25, 333?342 (1964).

4. Clark, M. F.: Purification and fractionation of alfalfa mosaic virus with polyethylene glycol. J. gen. Virol.3, 427?432 (1968).

5. Cooper, P.: In: ?Methods in Virology?,K. Maramorosch andH. Koprowski, eds., vol. 3, p. 244, New York: Academic Press, 1967.

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and prophylactic potential of a stabilized foot-and-mouth disease serotype Asia1 virus like particles designed through a structure guided approach;International Journal of Biological Macromolecules;2024-10

2. Factors Involved in Removing the Non-Structural Protein of Foot-and-Mouth Disease Virus by Chloroform and Scale-Up Production of High-Purity Vaccine Antigens;Vaccines;2022-06-24

3. An adventitious agent-free clonal cell line that is highly susceptible to foot -and-mouth disease virus;Biologicals;2021-07

4. Efficient Removal of Non-Structural Protein Using Chloroform for Foot-and-Mouth Disease Vaccine Production;Vaccines;2020-08-27

5. Immunogenicity and protective efficacy of 3A truncated negative marker foot-and-mouth disease virus serotype A vaccine;Applied Microbiology and Biotechnology;2020-01-30